The serotonin receptor 5-HT2B has been shown to be critically important during embryogenesis as the knockout of this gene in mice causes heart defects and embryonic lethality that impairs further analyses on other embryonic cell and tissue types. In the present review, we highlight how the use of Xenopus laevis, an alternative vertebrate model suitable for gene loss and gain of function analyses, has contributed to our understanding of the role of 5-HT2B signaling during development. In vivo studies showed that 5-HT2B signaling is not only required for heart development, but that it also has a crucial role in ocular and craniofacial morphogenesis, being involved in shaping the first branchial arch and the jaw joint, in retinogenesis and possibly in periocular mesenchyme development. These findings may be relevant for our understanding of congenital defects including human birth malformations. In addition, 5-HT2B appears to be required for the therapeutic actions of selective serotonin reuptake inhibitors commonly prescribed as antidepressant drugs to pregnant and lactating women. We discuss how the understanding of the molecular basis of serotonin signaling in a suitable animal embryogenesis model may open new lines of investigations and therapies in humans.
and anxiety-related disorders (Berton and Nestler, 2006) . These drugs inhibit the function of the serotonin transporter (5-HTT) inducing an accumulation of extracellular 5-HT and an increase of the magnitude and duration of the activity of 5-HT on 5-HT receptors (Shafer et al., 1999) .
In the adult brain 5-HT is synthesized in serotonergic neurons of the raphe nuclei that represent one of the most widely distributed neuronal systems in the vertebrate brain. In addition, several other tissues produce large amount of 5-HT, namely the pineal gland, where 5-HT is a precursor of melatonin, the enterochromaffin and myenteric cells of the gut and the bone (cf. Tsapakis et al., 2012) . Collectively, the tissue sources outside the brain produce about 95% of 5-HT.
Since the pioneer studies of Buznikov and his collaborators (reviewed in Buznikov, 2007) it has becoming clear that 5-HT, in addition to its well defined function as neurotransmitter, participates in the regulation of early development in many animal phyla before the onset of neurogenesis. 5-HT thus plays a role as a morphogen-like signal in development before it acts as a neurotransmitter (Lauder, 1993; Gaspar et al., 2003) . 5-HT synthesis and uptake become active at early stages during embryogenesis where it modulates a number of developmental processes including cell proliferation, migration and differentiation (Gaspar et al., 2003) . During mammalian embryogenesis 5-HT is supplied to the embryo by the maternal blood (Côté et al., 2007) . Moreover, an early transient placental source of 5-HT for the fetal circulation has been detected both in mice and humans (Bonnin et al., 2011) . In the central nervous system (CNS) serotonergic neurons are among the earliest neurons to be generated and 5-HT is released by growing axons before conventional synapses are established. In addition to the sites of 5-HT production, there are a number of cells that capture and store 5-HT, acting as 5-HT reservoirs during development. In mice uptake of 5-HT during early development is first observed in non-neural tissues such as the heart, the liver, the cranial mesenchyme, the migrating cranial neural crest cells (NCCs), dorsal ganglia and retinal ganglion cells (Lauder and Zimmerman, 1988; Narboux-Nème et al., 2008) . High affinity uptake of 5-HT in these structures highlights the involvement of 5-HT signaling in their development and suggests that 5-HT must be finely modulated.
So far evidence has been presented for 5-HT involvement in the establishment of left-right asymmetry, the craniofacial, limb, bone and heart development, the closure of the neural tube and neuronal differentiation during early neurogenesis (Whitaker-Azmitia, 2001; Levin et al., 2006; Beyer et al., 2012; Vandenberg et al., 2013) . In mice 5-HT has been found to influence the development of the whisker-barrel fields in the somatosensory cortex and the thalamocortical axon guidance, suggesting that dysfunction of 5-HT signaling during development may alter brain circuitry and functioning (Cases et al., 1996; Persico et al., 2001; Bonnin et al., 2007) . Recently, the generation of a knockout mouse line lacking the tryptophan hydroxylase 2 (Tph2), the brain enzyme for 5-HT synthesis, has shown that the lack of 5-HT in the brain produces severe abnormalities in the serotonergic circuitry (Migliarini et al., 2012) .
The biological actions of 5-HT are mediated by numerous cognate receptors that are grouped into seven classes . Except for 5-HT3 receptors, which are ligand-gated ion channels, all belong to G protein-coupled receptors and among these, the 5-HT2 receptors class seems to be particularly important in mediating the effects of 5-HT on embryonic development. Blockade of serotonergic signaling by the pan-5-HT2 receptor antagonist ritanserin perturbs development of the heart, the face and eyes both in mice and Xenopus, suggesting a conservation of this signaling pathway across vertebrate evolution (Choi et al., 1997; Bhasin et al., 2004; De Lucchini et al., 2005) . The 5-HT2B receptor has been shown to be an important regulator of the mouse cardiac morphogenesis since its genetic ablation leads to mouse embryonic and postnatal lethality due to abnormal heart development (Nebigil et al., 2000; Nebigil et al., 2001) . 5-HT2B knockout increases impulsive behaviors in mice and a human population-specific 5-HT2B stop codon was found to be associated with psychiatric diseases marked by impulsivity (Bevilacqua et al., 2010) . 5-HT2B receptor is also present on embryonic raphe neurons and takes part in the control of 5-HTT functions in differentiating serotonergic cells (Launay et al., 2006) . Recently, it has been shown to be required for the therapeutic actions of SSRIs (Diaz et al., 2012) . These findings indicate that the 5-HT2B receptor has important roles both in periphery and in the CNS and that it is one of the key mediators of 5-HT functions during development.
In this review we focus on the 5-HT2B receptor with the aim to show how the use of a suitable model system, Xenopus laevis, allowed to unveil new roles of this receptor thanks to the availability of sophisticated tools for manipulating embryos and gene functions. In particular, this review highlights how such studies provided detailed information about the mechanisms of 5-HT2B receptor function in two complex morphogenetic processes such as craniofacial and ocular development.
Xenopus as a vertebrate model system for developmental studies
Choosing a suitable animal model system to unveil new roles of the serotonin signaling during development is one of the most important steps for achieving meaningful results. Fig. 1 . Xenopus laevis as a model system to study gene function. On the left, the life cycle of Xenopus laevis. On the right, the gene loss of function strategy that specifically blocks the translation of a gene of interest by microinjecting specific morpholino oligos in one side of the embryo. Antisense morpholino is targeted to sequences close to the translation start site. The injected side is visualized by the co-injection of a reporter mRNA such as LacZ or GFP. Examples of chromogenic reaction for beta galactosidase (red) and GFP (green fluorescence) are shown in neural stage embryos.
Xenopus is a genus of aquatic frogs, native to southern Africa, that are tolerant to starvation, diseases and other insults that make them very easy to keep in captivity. Thus Xenopus has become a very widely used model organism for a variety of biological and biomedical researches. In particular, Xenopus is one of the most popular systems used in the field of developmental biology since it offers experimental advantages over other widely used model systems such as mice. These advantages come from the large number, accessibility and large size of the eggs, which can be easily fertilized in vitro producing huge numbers of synchronized embryos that can be observed developing from the first cell division to a tadpole in about 36 hours (Fig. 1) . The embryos can be easily manipulated, injected, grafted or labeled. In particular, researchers can easily manipulate gene functions in large numbers of embryos by using morpholino-modified antisense oligos and by mRNA mis-expression. This can be performed by injecting morpholinos or in vitro transcribed mRNAs into one cell of the two-cell stage embryos. This procedure provides a useful internal control, as the first cleavage results in gene down or up-regulation in only one side of the embryo (Fig. 1 ). In addition, the availability of a well-defined fate map of each blastomere allows addressing the microinjection in specific regions of the embryo so that a morpholino-mediated conditional knockdown approach can be easily obtained. This approach can overcome lethal effects and allows studying defects that appear in later stages of development. A homotipic transplant assay system has also been settled up in Xenopus embryos allowing detecting cell contribution to specific structures as well as the cell autonomous or non-autonomous contribution of specific gene activity in developmental processes (Borchers et al., 2000; Reisoli et al., 2010) (Fig. 2) . Xenopus is also successfully used for chemical genetics and drug screen studies (Wheeler and Brändli, 2009 ). In particular, chemical genetics provides a complementary approach to loss or gain of function mutations in the study of complex biological processes.
Public databases harbor the nucleotide sequences of almost 2 million expressed sequences tag (EST) from both X. laevis and X. tropicalis (the diploid sister species of X. laevis, whose genome is nearly sequenced) and microarrays are available for both species, thus an impressive collection of genomic and transcriptomic tools is rapidly becoming available for this model system.
Xenopus as a tetrapod shares a long evolutionary history with mammals: they share similarities at the level of the genomes, in organ development, anatomy and physiology and therefore it represents an excellent model to predict human biology.
5-HT and 5-HT2B receptor in Xenopus development
In Xenopus embryos 5-HT is present as a maternal pool in the eggs and the main components of the serotonergic system are expressed during the earliest stages of embryonic development (Fukumoto et al., 2005; Nikishin et al., 2012) .
In the CNS 5-HT is first produced by serotonergic neurons of the raphe nuclei at tailbud stages (van Mier et al., 1986) . Serotonergic cells are found in several other tissues or organs of the Xenopus larvae, such as the retina, the skin and the gut (Figs. 3; 4A). A specific population of neuroepithelial cells in Xenopus gills has also been shown to contain 5-HT (Saltys et al., 2006) .
The cloning of the Xenopus 5-HT2B cDNA revealed that the predicted protein is conserved among vertebrates, thus substantiating the role of Xenopus as a model system (De Lucchini et al., 2003) . Two alternative polyadenylation sites were found. The same situation was found in the puffer fish Tetraodon, so that a functional significance for the use of alternative polyadenylation sites, conserved in evolution, may be hypothesized (De Lucchini et al., 2001) . The genomic organization of the 5-HT2B receptor in Xenopus has not been addressed. However, in other organisms such as Tetraodon and humans, splice variants and truncated forms of the protein have been described (De Lucchini et al., 2001; Deraet et al., 2004) . It is interesting to note that in some instances mutations causing premature truncation of the protein product are related to human diseases such as fenfluramine-associated primary pulmonary hypertension (Blanpain et al., 2003) or with psychiatric diseases (Bevilacqua et al., 2010) .
In Xenopus the 5-HT2B mRNA expression has been detected in the post-hatching stages in proliferating regions of the CNS and retina, in cranial NCCs and in periocular mesenchyme (POM) (De Lucchini et al., 2003; Reisoli et al., 2008; Reisoli et al., 2010) .
Pharmacological treatments with the 5-HT2B antagonist ritanserin resulted in developmental defects strongly indicating that this receptor has a role in Xenopus embryogenesis. Morphological alterations included reduced pigmentation and heart defects with reduced heartbeats and pericardial edema. Similar heart defects have been found in ritanserin-treated mouse embryos (Choi et al., 1997) . Ritanserin-treated Xenopus embryos also revealed ocular defects characterized by small and dorsalized eyes with a protruding lens, delay in the closure of the optic fissure (coloboma) and disorganized retinal cytoarchitecture (De Lucchini et al., 2005) .
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Role of 5-HT2B signaling in retinal layering and ocular morphogenesis
The vertebrate retina is a powerful model to study how the nervous system is built up. Progenitor cells proliferate to generate six types of neurons and one type of glia, arranged into distinct layers. A number of molecules, including transcription factors and cell surface receptors, are involved in cell fate determination of retinal cell types (cf. Andreazzoli, 2009 for a review). In addition, both cell-intrinsic and -extrinsic cues must control the laminar organization of the retina. Recent evidence demonstrated that a wide range of neurotransmitters and their receptors are present during early stage of vertebrate retina development and it has been suggested that neurotransmitters may be numbered among the extracellular signals contributing to the retinal development. A precise coordination of retinal progenitor cell proliferation is essential for the formation of a functionally mature retina. Deregulated cell proliferation may in fact lead to dysplasia, retinal degeneration or retinoblastoma. There is now growing evidence that neurotransmitter systems modulate the proliferation and differentiation of retinal progenitor cells. The purinergic and muscarinic systems, for example, may take part in the control of retinoblasts proliferation while GABA, glutamate and dopamine appear to be involved in cell cycle exit and possibly in cell differentiation (for a review see Martins and Pearson, 2008) . 5-HT was predicted to be among the important players, as it is both produced and accumulated in the developing retina ( Figs. 3; 4A) . Moreover, studies carried out in mammals and in Xenopus demonstrated that the retina receives serotonergic afferents directly from serotonergic neurons located in the dorsal raphe nuclei denoted as serotonergic retinopetal projections (Gastinger et al., 2006) .
In Xenopus retina 5-HT accumulating amacrine cells are found starting from tailbud stage 35/36, a time when retinal stratification is underway, but before the elaboration of either of the plexiform layers (Frederick et al., 1989; Huang and Moody, 1997) . Different populations of 5-HT-immunoreactive amacrine and bipolar cells are found in the inner nuclear layer (INL) and in the gaglion cell layer (GCL) (displaced amacrine cells), but only a subtype of amacrine cells actually synthesizes 5-HT. Interestingly, the total number of 5-HT-immunoreactive cells steadily increases through the early tadpole stages, peaks at stage 44 and then decreases, whereas the number of 5-HT-synthesizing cells continually increases with age (14-fold, from 57 to 774 in adult). This fluctuation is due to a transient population of amacrine cells that accumulate 5-HT but do not synthesize it Huang and Moody, 1997) . The changes in cell number parallel the changes in absolute amount of 5-HT measured in the retina at different developmental stages (Frederick et al., 1989) . This may suggest that changes in 5-HT homeostasis at specific developmental periods influence retinal morphogenesis. Photoreceptor cells have also been reported to synthesize 5-HT, providing a supply of the substrate needed for the production of melatonin, in both mammals and amphibia Green et al., 1995) .
Different 5-HT receptors are expressed in the retina of mammals including humans (Sharif and Senchyna, 2006) . In Xenopus at least three 5-HT receptor mRNAs, coding for 5-HT1A, 5-HT2B and 5-HT2C respectively, are expressed in the larval retina (Marracci et al., 1997; De Lucchini et al., 2003) . Pharmacological evidence, coupled with the 5-HT2B receptor spatio-temporal gene expression pattern, suggested that this receptor could be the candidate mediator of the 5-HT action on retinal development. The most prominent 5-HT2B mRNA expression in the retina was found in the tadpole ciliary marginal zone (CMZ), which is the source of retinal stem cells during the amphibian larval and adult life. 5-HT2B mRNA was also localized in differentiated retinal cells mainly in the INL and GCL (De Lucchini et al., 2003) .
Loss of function experiments using morpholinos targeting the 5-HT2B mRNA resulted in loss of the characteristic retinal laminar cytoarchitecture (Fig. 4) . These morphological defects reproduced those observed after ritanserin treatment. The altered retinal morphology was not due to deregulation of gene expression of specific cell differentiation markers, as markers for retinal cell layers are expressed in 5-HT2B morphants. Both ritanserin and 5-HT2B morpholino treatments increased the number of apoptotic cells in Xenopus retina (De Lucchini et al., 2005) .
The upregulation of the 5-HT2B receptor activity did not affect retinoblast fate choice and terminal differentiation since all the main retinal cell subtypes were present in 5-HT overexpressing embryos, although they may be displaced outside their proper position and layer and rosette-like structures may form. Despite the severe alteration in layering, 5-HT2B up-regulated retinas did not show increase in apoptotic rate suggesting that 5-HT2B receptor may function in modulating retinoblast proliferation and survival (Reisoli et al., 2008) .
Further support to these findings came from in vitro studies showing that the 5-HT2B overexpression was found per se sufficient to promote Serotonin 2B receptor developmental role 5 cell proliferation in a neuroblastoma cell line (Reisoli et al., 2008) . These observations are in line with reports demonstrating that 5-HT, via 5-HT2B receptor, is an important regulator of cardiac myocyte proliferation and survival during mouse development (Nebigil and Maroteaux, 2001; Nebigil et al., 2003) .
The analysis of clones derived from lipofected retinoblasts constitutively expressing 5-HT2B showed a significant increase in the percentage of ganglion cells. Ganglion cells are very sensitive to cell death regulation and are specifically targeted by survival factors: 5-HT may be counted among these factors (De Lucchini et al., 2005) .
On the whole, the comparison between 5-HT2B gene loss and gain of function experiments points out that serotonin signaling via 5-HT2B receptor is essential for the frog mature retina functionality allowing the completion of the retinal layering process by supporting retinoblast proliferation and survival but it is not a determinant for specific retinoblasts differentiation.
Pharmacological and functional in vivo studies revealed another interesting aspect of the 5-HT2B function in ocular development. The altered orientation, position and conformation of the eye in the larval head cannot be directly explained by mechanisms involved in retinal histogenesis. Other ocular defects observed in 5-HT2B deregulated embryos are a shorter optic nerve and a failure of the choroid fissure closure or coloboma (Fig. 4) . A detailed analysis of the 5-HT2B mRNA expression pattern revealed its presence in the POM, a population of mesenchymal cells derived from both the mesoderm and cranial NCCs that surrounds the developing eye (Reisoli et al., 2008) . POM is known to provide multiple cell lineages necessary for normal ocular development as well as essential signals for the patterning of ocular primordia including the morphogenetic extension of the optic stalk, the anterior eye segment development and the optic fissure closure (Gage et al., 2005) . Additional studies are required to unveil the role of 5-HT2B signaling in POM development.
5-HT2B signaling and craniofacial morphogenesis/jaw joint formation: implications in human birth defects
The fact that 5-HT may play a role in mouse craniofacial morphogenesis was known from time, and malformations caused by exposure of cultured mouse embryos to selective 5-HT re-uptake inhibitors, such as fluoxetine (SSRI, Prozac) and 5-HT receptor antagonists were reported (Shuey et al., 1992; Moiseiwitsch, 2000) . Craniofacial morphogenesis is a complex developmental process requiring multiple and coordinated embryological events. The visceral skeleton of all jawed vertebrate embryos is organized into a rostrocaudal bilateral series of pharyngeal arches that are colonized by cranial NCCs, migrating along precise pathways from the mid-hindbrain segments of the neural tube. The NCC components of the branchial arches give rise to different skeletal elements that undergo profound changes during evolution (Sauka-Spengler and Bronner-Fraser, 2008 ). In addition, signals from the endoderm and the ectoderm, which overlie the branchial arches, are crucial for correct craniofacial development and in particular for the specification of the first branchial arch (reviewed in Minoux and Rijli, 2010) . Defining the network that orchestrates such a complex series of events is critically important as developmental mistakes may occur, leading to NCC-related developmental defects, such as craniofacial abnormalities, which account for one-third of all congenital human birth defects.
5-HT2B mRNA is present in the branchial arches of late tailbud Xenopus embryos, as well as in the branchial arches of the mouse embryo at ~E9 (Choi et al., 1997; Lauder et al., 2000; Reisoli et al., 2010) . However, developmental craniofacial defects in 5-HT2B knockout mouse embryos have not been reported, probably because the most penetrating phenotype of 5-HT2B mutant mice leads to early embryonic death in utero (Nebigil et al., 2000) . A possible role of the 5-HT2B signaling in craniofacial morphogenesis was suspected due to the potent teratogenic activity of its antagonists in cultured mouse embryos (Choi et al., 1997; Bhasin et al., 2004) . In spite of this evidence, the precise mechanisms of the 5-HT2B function in craniofacial morphogenesis awaited to be defined.
The first hint to a possible 5-HT2B role in the frog craniofacial morphogenesis came from overexpression experiments showing a craniofacial skeleton alteration. This phenotype was characterized by the formation of an ectopic cartilaginous element, by a reduction in the quadrate and subocular cartilages and by altered orbitohyoideus muscle connectivity. In 5-HT2B overexpressing embryos Xbap (also known as Nkx3.2 ), a gene codifing for a trascription factor expressed in the precursor cells of the jaw joint region, was ectopically expressed, resembling a mirror-image duplication of the wild-type Xbap expression. As shown by homotipic trasplant assay, the 5-HT2B activity in NCCs was sufficient, in a cell-autonomous manner, to generate the ectopic cartilage. More importantly, 5-HT2B activity was not only sufficient but also necessary to shape the first branchial arch skeletal elements. Knockdown of 5-HT2B expression in Xenopus embryos resulted in Xbap downregulation and in a fusion of a hypomorphic quadrate with the Meckel's cartilage into a single element, leading to the loss of the jaw joint ( Fig. 5 A-B) . The 5-HT2B signaling is therefore required to define and sustain the Xbap gene expression necessary for the jaw joint formation, which is one the major evolutionary novelties of vertebrates (Reisoli et al., 2010) . Another signaling pathway known to be able to positively control Bapx1 expression is endothelin 1 (Edn1) (Walker et al., 2007) . Since both endothelin and 5-HT2B signaling act through the PLC beta 3 effector (Raymond et al., 2001) , they could cooperate in modulating Xbap expression and reinforcing the PLC pathway in cranial NCCs during the first arch patterning (Reisoli et al., 2010) (Fig. 5C ). As the regulatory network involved in the specific expression of Bapx1 in vertebrates is conserved (Newman et al., 1997; Miller et al., 2003; Tucker et al., 2004) , it may be hypothesized that 5-HT2B signaling controls Bapx1 expression in mammalian embryos as well. This aspect, to be verified and further to SSRIs such as persistent pulmonary hypertension, cardiac defects and spontaneous abortion (Oberlander et al., 2009; Tuccori et al., 2009; Bellissima et al., 2012) . An association between congenital heart defects and the use of SSRIs in pregnancy has been demonstrated (Sadler, 2011) and these findings are in line with animal model studies showing a key role of 5-HT2B receptor signaling in heart development (Gaspar et al., 2003) . Interestingly, recent investigations demonstrated that 5-HT2B is required for serotonin selective antidepressant actions (Diaz et al., 2012) and in astrocytes fluoxetin and paroxetine (SSRIs) seem to act as subtype-specific agonists for 5-HT2B receptors (Zhang et al., 2010) .
Recently, the occurrence of OAVS, a syndrome characterized by abnormal development of facial structures derived from the first and second branchial arches, has been reported in an infant born to a woman with a history of prenatal fluoxetine treatment throughout her pregnancy, suggesting an involvement of 5-HT signaling also in human craniofacial morphogenesis (Farra et al., 2010) . Cardiovascular malformations and facial dysmorphism have been reported in two twins born to a woman who used paroxetine (SSRI) during pregnancy (Marsella et al., 2010) . A worldwide prospective analysis revealed that the incidence of mood and anxiety disorders is destined to progressively grow in the population so that a more extensive prescription of the SSRIs is expected to occur. This led to consecutive alerts by the U.S. Food and Drug Administration in explored, could be of interest particularly in the light of the possible involvement of BAPX1 in human birth defects, such as the oculo-articular-vertebral spectrum (OAVS), which exhibits alterations in the first and second branchial arch derivatives (Fischer et al., 2006) . In conclusion the data obtained in the experimental model Xenopus revealed that the 5-HT2B signaling can be included into the complex interactive network of extrinsic factors that regulates craniofacial skeleton development in vertebrates.
Concluding remarks
Work in a suitable vertebrate model system such as Xenopus embryos revealed novel roles of the 5-HT/5-HT2B signaling in eye and craniofacial morphogenesis. These findings are not only relevant in terms of evolutionary biology but may have consequence in our understanding of congenital defects, including human birth abnormalities.
The role of 5-HT2B receptors in ocular and facial morphogenesis is consistent with their expression in cranial NCCs, a transient population of migratory embryonic multipotent cells that arises from neural ectoderm and populates the pharyngeal arches. Disruption of cranial NCCs development lead to human congenital craniofacial and ocular defects that are included among the so called "neurocristopathies". Although these disorders are generally associated to genetic abnormalities, they can also be induced by prenatal exposure to teratogens. SSRIs represent a class of commonly used antidepressants in pregnant and lactating women and several epidemiological investigations report long-lasting molecular, physiological and behavioral changes in offspring prenatally exposed B C A Serotonin 2B receptor developmental role 7 2005 and 2006, stating that the use of SSRIs in pregnancy was associated with increased birth defects (Chambers et al., 2006 , Wogelius et al., 2006 . Prenatal exposure to SSRIs also impacts fetal brain development that may have long-term mental health implications (Hanley et al., 2013) . The mode of action of SSRIs suggests the involvement of complicated downstream mechanisms, including long-term changes in gene expression and neuroplasticity. Experimental studies in rodents have in fact shown that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behavior, such as increased anxiety in adulthood (Ansorge et al., 2008) . On the whole, these discoveries have significant implications for the prescription of antidepressants to pregnant women and should stimulate further animal models and human research efforts.
